Volume 54; Issue 5

Toxicon

Volume 54; Issue 5
1

Perioperative use of botulinum toxins

Year:
2009
Language:
english
File:
PDF, 108 KB
english, 2009
2

Disease-oriented approach to botulinum toxin use

Year:
2009
Language:
english
File:
PDF, 280 KB
english, 2009
4

Translocation of botulinum neurotoxin light chain protease by the heavy chain protein-conducting channel

Year:
2009
Language:
english
File:
PDF, 276 KB
english, 2009
5

Treatment of focal dystonias with botulinum neurotoxin

Year:
2009
Language:
english
File:
PDF, 117 KB
english, 2009
7

Central effects of tetanus and botulinum neurotoxins

Year:
2009
Language:
english
File:
PDF, 149 KB
english, 2009
8

Receptor and substrate interactions of clostridial neurotoxins

Year:
2009
Language:
english
File:
PDF, 570 KB
english, 2009
9

Unique properties of botulinum toxins

Year:
2009
Language:
english
File:
PDF, 52 KB
english, 2009
10

Migraine prophylaxis with botulinum toxin A is associated with perception of headache

Year:
2009
Language:
english
File:
PDF, 244 KB
english, 2009
11

Development of future indications for BOTOX®

Year:
2009
Language:
english
File:
PDF, 421 KB
english, 2009
13

Gynecological indications for the use of botulinum toxin in women with chronic pelvic pain

Year:
2009
Language:
english
File:
PDF, 132 KB
english, 2009
14

Engineered toxins: New therapeutics

Year:
2009
Language:
english
File:
PDF, 127 KB
english, 2009
15

Association of botulinum neurotoxins with synaptic vesicle protein complexes

Year:
2009
Language:
english
File:
PDF, 271 KB
english, 2009
16

Discussion of unique properties of botulinum toxins

Year:
2009
Language:
english
File:
PDF, 122 KB
english, 2009
17

Foreword

Year:
2009
Language:
english
File:
PDF, 108 KB
english, 2009
18

Botulinum toxin in the treatment of OAB, BPH, and IC

Year:
2009
Language:
english
File:
PDF, 231 KB
english, 2009
20

NeuroBloc®/Myobloc®: Unique features and findings

Year:
2009
Language:
english
File:
PDF, 218 KB
english, 2009
21

Xeomin is free from complexing proteins

Year:
2009
Language:
english
File:
PDF, 174 KB
english, 2009
23

Dysport®: Pharmacological properties and factors that influence toxin action

Year:
2009
Language:
english
File:
PDF, 235 KB
english, 2009
24

Basic and clinical aspects of BOTOX®

Year:
2009
Language:
english
File:
PDF, 227 KB
english, 2009
26

Editorial Board/Publication Information

Year:
2009
Language:
english
File:
PDF, 49 KB
english, 2009
27

Membership Application Form

Year:
2009
File:
PDF, 494 KB
2009